CDKN2A and urinary bladder cancer: The expression profile of CDC20, CDKN2A, CTSV, FOXM1, KRT23, MAGEA6, and S100A9 were significantly higher in bladder cancer specimens compared with normal bladder tissue in patients (Figure 5).